The effect of levodopa on stroke
Phase 2
- Conditions
- Ischemic stroke.Middle cerebral artery syndrome (I66.0+)
- Registration Number
- IRCT2014042017360N1
- Lead Sponsor
- Ahvaz jundishapour university of medical science
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 114
Inclusion Criteria
the patients with ischemic strroke in the MCA territory.
Exclusion criteria: 1.major depression, 2.cardiovascular disease 3.tricyclic therapy
4.SSRI therapy 5.dementia.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Motor function. Timepoint: three weeks after treatment. Method of measurement: Rivermead mobility index and Barthel index.;Language recovery. Timepoint: 4 weeks after treatment. Method of measurement: NIHSSS?.;Comparision between motor recovery of upper and lower limbs. Timepoint: 3 weeks after treatment. Method of measurement: Rivermead mobility index and Barthel index.
- Secondary Outcome Measures
Name Time Method Spastisity. Timepoint: 3 months after treatment. Method of measurement: Ashworth modified scale.